Christina Yau

Summary

Affiliation: Buck Institute for Age Research
Country: USA

Publications

  1. ncbi Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
    Christina Yau
    Buck Institute for Age Research, Redwood Boulevard, Novato, California 94945, USA
    Breast Cancer Res 10:R61. 2008
  2. ncbi Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
    Christina Yau
    Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945, USA
    Breast Cancer Res 9:R59. 2007
  3. ncbi Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
    Yamei Zhou
    Buck Institute for Age Research, Novato, CA 94945, USA
    BMC Cancer 7:59. 2007
  4. ncbi Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer
    Corina Marx
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Mol Pharmacol 71:1525-34. 2007
  5. ncbi A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
    Christina Yau
    Buck Institute for Age Research, Novato, CA 94945, USA
    Breast Cancer Res 12:R85. 2010
  6. ncbi Novel pathways associated with quinone-induced stress in breast cancer cells
    Christopher C Benz
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, Novato, CA 94945, USA
    Drug Metab Rev 38:601-13. 2006
  7. ncbi Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers
    Yamei Zhou
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Int J Biochem Cell Biol 37:1130-44. 2005
  8. ncbi Ageing, oxidative stress and cancer: paradigms in parallax
    Christopher C Benz
    Christopher C Benz and Christina Yau are at the Buck Institute for Age Research, Novato, California 94945, USA
    Nat Rev Cancer 8:875-9. 2008
  9. ncbi Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
    Christina Yau
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Breast Cancer Res Treat 126:803-10. 2011

Collaborators

Detail Information

Publications9

  1. ncbi Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
    Christina Yau
    Buck Institute for Age Research, Redwood Boulevard, Novato, California 94945, USA
    Breast Cancer Res 10:R61. 2008
    ..Oxidative stress can modify estrogen receptor (ER) structure and function, including induction of progesterone receptor (PR), altering the biology and clinical behavior of endocrine responsive (ER-positive) breast cancer...
  2. ncbi Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
    Christina Yau
    Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945, USA
    Breast Cancer Res 9:R59. 2007
    ..Except for inherited forms of breast cancer, however, there is little genetic or epigenetic understanding of the biological basis linking aging with sporadic breast cancer incidence and its clinical behavior...
  3. ncbi Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
    Yamei Zhou
    Buck Institute for Age Research, Novato, CA 94945, USA
    BMC Cancer 7:59. 2007
    ..Signaling pathways that converge on two different transcription factor complexes, NFkappaB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen...
  4. ncbi Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer
    Corina Marx
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Mol Pharmacol 71:1525-34. 2007
    ....
  5. ncbi A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
    Christina Yau
    Buck Institute for Age Research, Novato, CA 94945, USA
    Breast Cancer Res 12:R85. 2010
    ....
  6. ncbi Novel pathways associated with quinone-induced stress in breast cancer cells
    Christopher C Benz
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, Novato, CA 94945, USA
    Drug Metab Rev 38:601-13. 2006
    ....
  7. ncbi Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers
    Yamei Zhou
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Int J Biochem Cell Biol 37:1130-44. 2005
    ....
  8. ncbi Ageing, oxidative stress and cancer: paradigms in parallax
    Christopher C Benz
    Christopher C Benz and Christina Yau are at the Buck Institute for Age Research, Novato, California 94945, USA
    Nat Rev Cancer 8:875-9. 2008
    ..of gene expression in age-controlled breast cancer cases indicate that this deduction is false, posing parallax views of these two paradigms, and highlighting the unanswered question: does ageing cause or simply permit cancer development?..
  9. ncbi Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
    Christina Yau
    Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA
    Breast Cancer Res Treat 126:803-10. 2011
    ....